Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects

Citation
Mc. Liu et al., Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects, J ALLERG CL, 108(1), 2001, pp. 29-38
Citations number
40
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
108
Issue
1
Year of publication
2001
Pages
29 - 38
Database
ISI
SICI code
0091-6749(200107)108:1<29:EOPOTC>2.0.ZU;2-H
Abstract
Background: Systemic glucocorticoids are a major therapy for the management of allergic inflammation and asthma; however, information about their effe cts in vivo are limited . Objective: This study was performed to examine the effects of prednisone on inflammatory mediators, cytokines, and cellular responses in the model of segmental allergen challenge (SAC) of allergic asthmatic subjects. Methods: The effects of a 3-day pretreatment with oral prednisone (30 mg tw ice daily) on the physiologic and inflammatory responses to SAC were studie d in 10 allergic asthmatic subjects in a double-blind, placebo-con trolled, crossover protocol. Results: Prednisone improved baseline FEV1 by 10% and modestly inhibited th e SAC-induced fall in FEV1 at 30 minutes and at 6 to 8 hours. Five minutes after challenge, levels of histamine, PGD(2),9 alpha ,11 beta -PGF(2), and thromboxane B-2 increased in bronchoalveolar lavage fluid (median increase, 5- to 14-fold); prednisone did not inhibit these responses. Prednisone inh ibited (median decrease, 66 % -97 %) the total influx of inflammatory cells , specifically eosinophils, basophils, and some subsets of T lymphocytes (C D4, CD45RA, and CD45RO cells) assessed 19 hours after SAC, but it did not i nhibit the influx of neutrophils. Increases in soluble E-selectin, kinins, and albumin were also inhibited by the glucocorticoid (median decrease, 36 %-74 %). Prednisone treatment inhibited the appearance of mRNA, protein, or both for T(H)2 cytokines (IL-4 and IL-5), as well as for IL-2 and transfor ming growth factor alpha, but did not inhibit increases of immunoreactive G M-CSF in bronchoalveolar lavage fluid. Conclusion: These studies indicate that prednisone suppresses multiple comp onents of allergic airway inflammation, including cell recruitment, adhesio n molecule expression or release, airway permeability, and production of cy tokines potentially involved in airway immunity or remodeling.